Union Health Minister highlights India’s progress in universal health coverage, digital health, AI strategy and global vaccine cooperation during plenary session in Geneva
The drug also delivered a disease control rate (DCR) of 83.3% in high-dose cohorts and a mean progression-free survival of 6.3 months in SCLC patients
Despite the strong results, investigators cautioned that the study has limitations, including its open-label Phase II design, lack of randomization, and reliance on a historical external control arm
According to the analysis, just 23% of patients aged 18–29 were formally diagnosed with TD
Africa CDC activates continental coordination measures; consultations underway on possible Public Health Emergency declaration
The 38% adjusted EBITDA margin of base business has been supported by robust growth in the CDMO segment
The Ibuprofen business posted a negative EBITDA of Rs. 179 million in Q4 despite revenue rising 61% year-on-year to Rs. 849 million
The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy
This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces
Subscribe To Our Newsletter & Stay Updated
